BayWa's April Deadline: A €107 Million Test of Creditor Confidence

The clock is ticking for German agricultural trading group BayWa. By April 30, a payment of approximately €107 million from the partial sale of its Cefetra unit and repaid shareholder loans is due to hit its accounts. Far from a simple liquidity boost, this cash injection serves as the primary bargaining chip in high-stakes negotiations with core creditor banks DZ Bank and HVB. Their consent to extend a standstill agreement until autumn 2026 is the linchpin without which the entire multi-billion euro restructuring plan collapses.

Investors are navigating in the dark. The audited group financial statements for 2025 are not expected until the fourth quarter of 2026, a delay caused by the complexity of ongoing structural measures. This lack of a reliable valuation basis is reflected starkly in the share price performance. The stock has fallen nearly 20% since the start of the year and trades roughly 21% below its 200-day moving average, a clear signal of deep market skepticism.

Parallel to the bank talks, BayWa is attempting to sell its nearly 74% majority stake in the profitable New Zealand fruit trading subsidiary T&G Global. Goldman Sachs has been managing the sale process since March 2026. T&G returned to the black in 2024 with a net profit of $16 million on revenue of $1.3 billion, and owns attractive apple brands like Envy and Jazz. However, the process is being hampered by minority shareholder Joy Wing Mau Group in Hong Kong. Even a successful sale, estimated to yield around €300 million, would only be a small component of the wider rescue effort. BayWa’s total refinancing gap stands at €4 billion, of which only €1.3 billion has been secured so far.

Should investors sell immediately? Or is it worth buying BayWa?

The financial distress has already forced painful write-downs among the company's cooperative owners. Bavarian cooperative banks have already written off €132 million—60% of a €220 million promissory note—with the cooperative association warning of further write-downs potentially leading to a total loss. Governance uncertainty adds another layer, with three supervisory board members having recently departed and a shareholder meeting to confirm their successors yet to be scheduled.

A significant and separate pressure point is the energy subsidiary BayWa r.e. Its financial projections have been severely downgraded following the US "One Big Beautiful Bill Act," which significantly cut subsidies for renewable energy. The original EBITDA forecast of €230 million for 2028 has been abandoned; the company now does not expect to reach €150 million in EBITDA until 2030. This revaluation of the energy unit, which sold over 530 megawatts of project capacity in 2024, remains pending and threatens to open further valuation gaps in the balance sheet.

The €107 million payment is therefore a critical milestone. It will test whether the creditor banks are willing to grant BayWa the necessary runway to execute asset sales like T&G. Without their agreement on the standstill, the management's operational basis for the entire restructuring vanishes. For shareholders, a clear fundamental picture remains distant, hinging entirely on successful creditor negotiations in the coming days and the long-delayed financial statements over a year from now.

Ad

BayWa Stock: New Analysis - 12 April

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

en | DE0005194005 | BAYWAS | boerse | 69129721 |